期刊文献+

临床分离阴沟肠杆菌的耐药性分析 被引量:5

Resistant Rate of 132 Clinical Strains of Enterobacter Cloacae
下载PDF
导出
摘要 目的 分析阴沟肠杆菌耐药机理和现状 ,指导临床合理应用抗菌药物。方法 用K B纸片扩散法对1 32株阴沟肠杆菌做 2 0种抗菌药物的敏感试验 ,并对 80株阴沟肠杆菌进行超广谱 β 内酰胺酶 (ESBLs)测定。 结果 对 2 0种抗菌药物的敏感试验显示 ,阴沟肠杆菌对 β 内酰胺类抗生素显示较高耐药 ;对氨基糖苷 ,喹诺酮类等也有不同程度的耐药 ,对碳青霉烯类有很高的抗菌活性。结论 阴沟肠杆菌对临床常用的抗菌药物呈高耐和多重耐药 ,其耐药机制为 β 内酰胺酶产生的ESBLs和AmpC酶 ;环丙沙星、左氟沙星、头孢吡肟等可作为治疗其感染的首选用药 ,亚胺培南可作为二线用药 。 Objective To analyze drug resistant mechanism and situation and direct clinical prudent using of antibiotics. Methods By using paper disc diffusion method, 132 clinical strains of E.cloacae were tested for susceptibility,and 80 strains of E.cloacae were detected for the production of ESBLs.Results The susceptibility test results showed, All E.cloacae isolated had a relatively high resistance to β lactamase, and carbopenem had high antibioltic activity.Conclusions Clinical strains showed multiresistance to usual antibiotics, and Quinolone and Cefepime may be used as the leading antibiotics, and Imipenem is the second choice.
出处 《医学新知》 CAS 2003年第1期20-22,共3页 New Medicine
关键词 临床分离 阴沟肠杆菌 耐药性 药物敏感试验 Β-内酰胺酶 抗菌药 Enterobacter cloacae Drug susceptibility test β lactamase
  • 相关文献

参考文献4

二级参考文献35

  • 1Bennett PM, Chopra I. Molecular basis of β-lactamase induction in bacteria[J]. Antimicrob Agents Chemother, 1993, 37(2): 153-158.
  • 2Sanders CC, Bradford PA, Ehrhardt AF et al. Penicillin-binding proteins and induction of AmpC β-lactamase[J]. Antimicrob Agents Chemother, 1997, 41(9): 2013-2015.
  • 3Jones RN. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes[J]. Diagn Microbiol Infect Dis, 1998, 31(3): 461-446.
  • 4Haruta S, Nukaga M, Taniguchi K et al. Resistance to oxyimino β-lactams due to a mutation of chromosomal β-lactamase in Citrobacter freundii[J]. Microbiol Immuno, 1998, 42(3): 165-169.
  • 5Korfmann G, Sanders CC, Moland ES. Alterd phenotypes associated with ampD mutations in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35(2): 358-364.
  • 6Bartowsky E, Normark S. Purification and mutant analysis of Citrobacter freundii AmpR: the regulator for chromosomal AmpC β-lactamase[J]. Mol Microbiol, 1991,5(7): 1715-1725.
  • 7Stapleton P, Shannon K, Phillips I. DNA sequence differences of ampD mutants of Citrobacter freundii[J]. Antimicrob Agents Chemother, 1995, 39(11): 2494-2498.
  • 8Bush K , Jacoby GA, Mederios AA. A functional classification scheme for β-lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995, 39(6): 1211-1233.
  • 9Papanicolaou GA, Mederios AA, Jacoby GA. Novel plasmid-mediatedβ-lactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 1990, 34(11): 2200-2209.
  • 10Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamases in Klebsiella pneumoniae including resistance to cephamycins[J]. Infection, 1989, 17(5): 316-321.

共引文献287

同被引文献29

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部